Loading clinical trials...
Loading clinical trials...
Pilot Study to Assess the Safety and Efficacy of Switching the Nnrti or pi to Maraviroc in Hiv-1-infected Subjects With Persistent Viremia Suppression
Conditions
Interventions
maraviroc
control group
Locations
3
Spain
Germans Trias i Pujol Hospital
Badalona, Barcelona, Spain
Lluita contra la Sida Foundation, HIV Unit, Irsi Caixa Foundation
Badalona, Barcelona, Spain
Lluita contra la Sida Foundation, HIV Unit
Badalona, Barcelona, Spain
Start Date
October 1, 2009
Primary Completion Date
May 1, 2012
Completion Date
May 1, 2012
Last Updated
January 24, 2013
NCT01875588
NCT07071623
NCT04929028
NCT03087253
NCT07199335
NCT05419024
Lead Sponsor
Germans Trias i Pujol Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions